Outcomes in mAb-Treated Ferrets: Ebola Virus Recrudescence Study

32 ferrets were inoculated with a lethal dose of Ebola virus and treated with a monoclonal antibody cocktail. The dataset likely contains outcomes for 14 survivors, 8 acute fatalities, and 10 atypical recrudescence fatalities between 12 and 18 days post-infection. The data was authored by Wenguang Cao and last updated on 2026-05-04.

Use Cases

• Modeling survival outcomes based on antibody treatment dosage and timing.
• Analyzing viral load dynamics in blood and organs like the brain, liver, and spleen.
• Studying the correlation between inflammatory markers and pathological changes in the central nervous system.
• Investigating the timing and characteristics of atypical disease recrudescence versus acute infection.

Strengths

• Data from a controlled animal study with 32 subjects and three distinct outcome groups.
• Includes specific temporal markers such as days post-infection (5–8 days for acute, 12–18 days for atypical).
• Published under a permissive CC-BY-4.0 license for reuse.

Limitations

• Row count and column-level documentation are unknown, requiring manual inspection after download.
• The dataset is very small at 9.5 KB, indicating limited scope and likely a summary table rather than raw experimental data.

Provenance

Source

figshare

Collection Method

Likely contains results from a laboratory animal study.

Time Range

Experimental timeline measured in days post-infection.

Freshness

Last updated 2026-05-04 18:01:23; freshness should be verified.

Geography

null